¶ÔôÇ»ù±½¸Ê°±Ëá,p-HydroxyphenylglycineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±£³ÖÂÊ,retentionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë¥ÍËÆÚ,FadingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ⱦ¶¾,poisoningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þÇâÈôµ¤Ã÷,DihydrorhodamineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÛÍ´¸ÐÊÜÆ÷,NociceptorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á÷µ÷ÖÐÐÄÓÃÒÖÓôÁ¿±í,CES-DÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔ°×ÖÊÏ¡ÊèÖ¢,LeukoaraiosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Rnd1µ°°×,Rnd1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Ö²¿ÄÔѪÁ÷¹à×¢,regional cerebral blood flowÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶÷±ØÆÕÈí½ºÄÒ,dl-3-butylphthalideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÃÒ©Çé¿ö,MedicationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÀàȱѪÔÙ¹à×¢,ischemia-like-reperfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¹Ìå½áºÏ,complement-bindingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÒÐý×ôÆ¥¿Ë¡,S-ZopicloneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×ËữRb,Phospho-RbÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ê״η¢×÷,First-episodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÇÌÇÄò²¡ÐÔ,Non-diabeticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µç³é´¤ÖÎÁÆ,ECTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Beclin1»ùÒò,Beclin1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂѪ¹ÜÐγÉ,neovascularizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³¬Ñõ»¯ÎïÆç»¯Ã¸1,SOD1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈÄýÊõ,ThermocoagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔÈí»¯,EncephalomalaciaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ç¿ÆÈÕϰ,OCDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TaqIA,PolymorphismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾³ÉÏñ,NeuroimagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¤ëÄÊÍ·ÅøÀà,KallikreinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾±¶¯Âö¹Üǻֱ¾¶,CCADÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÍâ·¢Éú,EctogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅÁÂÞÎ÷¶¡,paroxetineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ү³²¼ÀÊÇ¿ÆÈÁ¿±í,Y-BOCSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±½¶þµªÀà,benzodiazepinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°±¼ºÏ©Ëá,vigabatrinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
רע´ï,ConcertaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ëë×Ì춬ø-12,caspase-12Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡µçͼ(EMG),Electromyogram(EMG)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Å¹²Õñ¾²ÂöѪ¹Ü³ÉÏñ,MRVÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÁ´ïÀ·î,edaravoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏËÈÜøԼ¤»îÒÖÖÆÎï,PAI-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎÄÀ·¨ÐÁ»ºÊͼÁ,venlafaxineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õò¾²Êõ,sedationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Çç¶û,OzagrelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥¹â×Ó·¢Éä¶Ï²ãɨÃè,SPECTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ÐÂÉú,NeurogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÜѪÁ×Ö¬Àà,lysophospholipidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶î,ForeheadÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µçÊÓ͸ÊÓ¼ì²é,VideofluoroscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒßÓ¡¼£·´Ó¦,immunoblottingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÏÙ×éÖ¯,ThymusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƤÖÊ·¢ÓýÕϰ,disorders of cortical developmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˺ÍÑÊõ,avulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²©Ë¼Çå,BriskingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°Úλ,positioningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ϣ˹Ãô,HismanalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ìå¸Ð,SomatosensoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔ½ºÖÊϸ°ûÁö,GliomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÕØÊÂÕØ»ö,troublemakingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ñ²ðï/²¢·¢Ö¢,Epilepsy/complicationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¨Ìضû16ÖÖÈ˸ñÒòËØÁ¿±í,16PFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¬½ÓËØ¿¹Ìå,Titin-AbÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾«ÉñÍâ¿Æ,PsychosurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Í´¾õÒì³£,allodyniaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÐÎÖ¸Êý,BMIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×¢Ò⹦ÄÜ,AttentionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ǿֱÕóÂÎÐÔ,tonic-clonicÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔʵÖÊ,ParenchymaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ñ²ðï/²¡Òòѧ,Epilepsy/EtiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÇÒäÉÌ,MQÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°±/ѪҺ,Ammonia/BloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ú²¿,earÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³£¹æÄÔµçͼ,REEGÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƤÖʵçͼ,electrocorticogramÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂçÌ©,luotaiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Ô°×ÇòÄڲಿ,GPiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°±¶¡Èý´¼,tromethamineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʧд֢,AgraphiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅÁÂÞÎ÷Í¡/ÖÎÁÆÓ¦ÓÃ,paroxetine/TUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Rhoµ°°×,Rho proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
LDL/ѪҺ,LDL/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ù²è·ÓÁÚ¼×»ù×ªÒÆÃ¸,Catechol-O-methyltransferaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾½ºÖÊÁö/Õï¶Ï,glioma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÐÄÔÖÜΧ·Ç¶¯ÂöÁöÐÔÖëÍøÄ¤ÏÂÇ»³öѪ,PNSHÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ç¿·ÈëÄÔ,prodynorphinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÒ©ÄÍÒ©»ùÒò-1,mdr1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÒÅݵ¥°·×ªÔËÌå,VMAT2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄýѪ״̬,CoagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºÚÖÊÎÆ×´Ìå,nigrostriatumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶à¶¯,HyperactivityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ç⻯Âó½Ç¼î,dihydroergotoxineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËèÇÊÍÑʧ,DemyelinationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÄÚ΢͸Îö,MicrodialysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾«Éñ´´ÉË,spiritual traumaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÒõ£µ¨¼î(Ach),acetylcholineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʧд,AgraphiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹Èë׸ÊëÄÛÏ»ù×ªÒÆÃ¸,glutathione-S-transferaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾Ê³µÀ³¬Éù,echocardiographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖØ¾ÆÊ¯ËῨ°ÍÀÍ¡,RivastigmineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÉÀÃ÷,CoramineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ñ²ý¢,EpilepsyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|